Weekly Digest – December 2025 Weekly Digest – December 2025 02 December 2025: MHRA approves Tisotumab vedotin for the treatment of cervical cancer The MHRA has approved Tisotumab vedotin (Tivdak) for adults with recurrent or metastatic cervical cancer whose disease […]
Contact:
info@ciscientists.com
+1-908-212-7484
Optimal Dose
For a subscription, please provide your email id